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Abstract
In many medical studies, an ultimate failure event such as death is likely to be af-
fected by the occurrence and timing of other intermediate clinical events. Both event
times are subject to censoring by loss-to-follow-up but the nonterminal event may
further be censored by the occurrence of the primary outcome, but not vice versa.
To study the effect of an intervention on both events, the intermediate event may
be viewed as a mediator, but conventional definition of direct and indirect effects is
not applicable due to semi-competing risks data structure. We define three principal
strata based on whether the potential intermediate event occurs before the potential
failure event, which allow proper definition of direct and indirect effects in one stratum
whereas total effects are defined for all strata. We discuss the identification condi-
tions for stratum-specific effects, and proposed a semiparametric estimator based on
a multivariate logistic stratum membership model and within-stratum proportional
hazards models for the event times. By treating the unobserved stratum membership
as a latent variable, we propose an EM algorithm for computation. We study the
asymptotic properties of the estimators by the modern empirical process theory and
examine the performance of the estimators in numerical studies.
Keywords: Illness-death model; Missing data; Principal stratification; Proportional hazards
model; Survival analysis.
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1. Introduction
Evaluating the causal effects of an intervention on a clinical outcome is a common theme in
many medical studies. After an overall relationship between the intervention and outcome
is established, it is often of further interest to understand the biological or mechanistic
pathways that contribute to the causal treatment effect. Causal mediation analysis is often
utilized to disentangle the total treatment effect by decomposing it into the indirect effect,
i.e., the effect exerted by intermediate variables (mediators), and the direct effect, i.e., the
effect involving pathways independent of the hypothesized mediators. A number of methods
were proposed for causal mediation analysis with survival outcomes, for a single mediator
measured at study entry (Lange and Hansen 2011; VanderWeele 2011; Tchetgen Tchetgen
2011; Lange et al. 2012) and for longitudinal mediators (Lin et al. 2017; Zheng and van der
Laan 2017; Didelez 2019; Vansteelandt et al. 2019; Aalen et al. 2020).
In many biomedical studies, intermediate, non-terminal landmark events are recorded
in addition to the primary failure event because they are important to evaluate prognosis.
Due to the ordering of the two events, the non-terminal event is subject to censoring by the
occurrence of the terminal event, but not vice versa, such that semi-competing risks data are
observed (Fine et al. 2001). In this paper, we consider a setting where a non-terminal event
may serve as a mediator for individuals to whom the event would occur before the terminal
event. An example is a multi-center trial of allogeneic bone marrow transplants in patients
with acute leukemia (Copelan et al. 1991; Klein and Moeschberger 2006), where the primary
interest is on the effect of different treatment regimen (methotrexate + cyclosporine vs
methylprednisolone + cyclosporine) on the survival time. The event time of an intermediate
endpoint, chronic graft-versus-host disease (GVHD), is a major side effect of the transplant
that can be lethal. However, some patients died without experiencing GVHD, such that
GVHD event time is subject to censoring by the death time.
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Causal mediation analysis with semi-competing risks data is particularly challenging.
First, the mediator is only well-defined for those who would have the non-terminal event de-
veloped before the occurrence of the primary event. Therefore, the conventional definition
of natural indirect and direct effects based on replacing the counterfactual of mediator un-
der one treatment by that under the other can hardly apply to the entire population. This
challenge is similar to that of the ‘truncation-by-death’ problem (Zhang and Rubin 2003;
Comment et al. 2019), where the primary outcome is only available if the terminal event
does not occur. However, there is a substantial difference in that the primary outcome of
interest is the terminal event in our setting. Moreover, the semi-competing risks data struc-
ture, that is, the primary event may censor the intermediate event but not vice versa, posts
additional challenges in the identifiability of parameters. Upon finishing this paper, we
became aware of the newly accepted paper by Huang (2020) which considered this problem
by a counting process framework. The problem formulation, estimand and assumptions
are all very different from our work. For instance, we do not make sequential ignorability
assumptions on surviving subpopulations at arbitrary post-treatment time, because those
evolving subpopulations are generally healthier than the baseline study population before
the treatment is assigned.
In this paper, we consider a novel principal stratification approach to define causal
mediation effects in the subgroup where the intermediate event happens when given either
treatment, i.e., those susceptible to the intermediate event under both treatments. The
notations and settings are given in Sections 2.1 and 2.2. We discuss the identification
conditions needed for estimating the stratum-specific natural indirect and direct effects
in Section 2.3, and proposed a semiparametric estimator based on a multivariate logistic
stratum membership model and within-stratum proportional hazards models for the event
times in Section 2.4. By treating the unobserved stratum membership as a latent variable,
we propose an EM algorithm for computation of the nonparametric maximum likelihood
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estimator in Section 2.5. We also study the asymptotic properties of the estimators using
the modern empirical process theory in Section 2.6 and examine the performance of the
estimators in simulation studies Section 3. An analysis of data from a clinical trial is
given in Section 4, and concluding remarks are included in Section 5. Proofs and detailed
derivations are given in the Appendix.
2. Methods
2.1. Notations for Observed Data
Let A be a binary treatment, T be the time to a primary event of interest and M be
the time to an intermediate, non-terminal event. The intermediate event time M may be
censored by the occurrence of the primary event, but not vice versa, such that we observe
semi-competing risks data. For example, A is a treatment for prolonging survival time, T
is the time to death, and M is the time to cancer progression. The occurrence of death
may censor the cancer progression onset, but not vice versa.
Let X be a collection of baseline covariates that may be associated with either or both
events. Let C denote a censoring time for the primary event, for example, end of follow-up
time. Then, we observe Y ≡ min(T,C) and ∆T = I(T ≤ C) for the primary event, and
Z ≡ min(M,Y ) and ∆M = I(M ≤ Y ) for the intermediate event. The observations are
versions of the counterfactual variables that we define as follows.
2.2. Counterfactuals and Causal Estimands
To define causal mediation effects of interest, we adopt the potential outcomes framework.
In conventional causal mediation analysis based on counterfactuals,M(a) denotes the coun-
terfactual nonterminal event time when the treatment is set to a and T (a,m) denotes the
counterfactual terminal event time when the treatment is set to a and the nonterminal
event time (mediator) is set to m. A comparison of T (a,M(a)) with T (a,M(a∗)) would
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define a measure of the natural indirect effect of changing the mediator fromM(a) toM(a∗)
and a comparison of T (a,M(a∗)) with T (a∗,M(a∗)) would define a measure of the natural
direct effect of changing the treatment from a to a∗. Both natural indirect and direct ef-
fects involve the term T (a,M(a∗)), i.e., the counterfactual outcome for the terminal event
time when the treatment is set to a and the nonterminal event time is set to M(a∗), the
counterfactual nonterminal event time when the treatment is set to a∗.
However, these conventional definitions are inadequate for semi-competing risk settings
and needs to be modified for the following reasons. The potential non-terminal event may
or may not occur before the potential primary event time under different treatment as-
signments. When the potential primary event happens before the potential intermediate
event, the value of the mediator is not well-defined (and is often set to ∞ by convention)
and in such a case the potential primary event time shall not be dependent on an arbi-
trary m greater than the potential primary event time. Due to these considerations, we
examine causal effects based on our proposed principal stratification approach, extended
from Frangakis and Rubin (2002). Intuitively, we stratify the study population into latent
classes identified by U with 3 categories based on whether they are susceptible to the non-
terminal event under different treatment assignments. For an individual with U = 1, we
assume the residual counterfactual event time T (a,m)−m is non-negative with probability
1 for m ∈ M, where M is the support of M(a). This does not only imply susceptibility
under either treatment, but also implies T (a,M(a∗)) > M(a∗) for a 6= a∗. For U = 2,
we assume M(1) = ∞ with probability 1, and T (1,m) is only defined for m = ∞, while
(T (0,m),M(0)) is defined for m ∈ M such that T (0,m) −m is non-negative with prob-
ability 1. That is, the treatment “prevents” the subject with U = 2 from having the
intermediate event. For individuals with U = 3, we assume M(0) = M(1) = ∞ with
probability 1 and T (a,m) is defined for a ∈ {0, 1} with m = ∞. That is, they are always
“non-susceptible” to the non-terminal event. Here, we assume that the fourth stratum with
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the nonterminal event only present in the treated does not exist. This restriction is along
the same line as the “no defier” assumption commonly adopted in the instrumental variables
methods, suggesting that the treatment effect is “monotone” and no reversed effect for the
subjects (Angrist et al. 1996).
Remark 1. The defined strata (and associated stratum-specific effects) are substantially
different from the survivors’ principal stratum (and the survivor average causal effect
(SACE)) that is commonly defined in “truncation by death” literature (Zhang and Ru-
bin 2003; Comment et al. 2019). In particular, the survivors’ principal stratum is defined
by {T (0) ≥ t, T (1) ≥ t} for some fixed time t in Comment et al. (2019), whereas our
definition does not depend on any arbitrary post-treatment time t.
Remark 2. Lin et al. (2017) explained the difficulties in defining natural mediation effects
in survival context with longitudinal mediators. They defined interventional effects in
a discrete-time setting, where the mediators and past survival status are subject to a
hypothetical intervention. They mentioned that principal stratification as an alternative
framework to avoid such hypothetical intervention, but did not explore further. We consider
a different setting that shares some of the difficulties, but also with unique data structure
so that principal strata can be defined.
Using our modified definition, the convention T (a) = T (a,M(a)) still holds for all
individuals, while T (a,M(a∗)), a 6= a∗, is only well-defined for U = 1. Therefore, the
stratum-specific indirect and direct effects can only be defined for subjects with U = 1,
while total effects are still well-defined for U = 2 and U = 3. In light of these observations,
for stratum with U = 1, we define the stratum-specific natural indirect and direct effects
as
NIE1(t;x) = Pr{T (1,M(1)) ≥ t|X = x, U = 1} − Pr{T (1,M(0)) ≥ t|X = x, U = 1}
(1)
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and
NDE1(t;x) = Pr{T (1,M(0)) ≥ t|X = x, U = 1} − Pr{T (0,M(0)) ≥ t|X = x, U = 1}.
(2)
In stratum with U = 2, T (1,M(0)) is not well-defined because T (1,m) is only defined for
m =∞ andM(0) <∞ with probability 1. However, T (a) = T (a,M(a)) is still well-defined
and the stratum-specific total effect is
TE2(t;x) = Pr{T (1) ≥ t|X = x, U = 2} − Pr{T (0) ≥ t|X = x, U = 2} .
In stratum with U = 3, M(0) = M(1) = ∞ and T (1,M(0)) = T (1,M(1)) so there is no
indirect effect. The stratum-specific total effect can still be defined as
TE3(t;x) = Pr{T (1) ≥ t|X = x, U = 3} − Pr{T (0) ≥ t|X = x, U = 3}.
Remark 3. In principle, a mediator shall satisfy temporal precedence, that it shall occur
before the primary event. Therefore, one can view that the mediator is technically absent
in U = 3, and an attempt to define mediation effects would be futile. In U = 2, the
presence of the mediator before the primary event only happens in one treatment level
with certainty. As a result, one cannot fix the mediator level at a different treatment level,
and mediation effects cannot be defined. Note that in U = 2, TE2 can be interpreted as
the treatment effect in survival among individuals whose mediating events are prevented
by the treatment.
2.3. Identification
To identify the stratum-specific natural indirect and direct effects and stratum-specific total
effects, we impose the following assumptions.
Assumption 1 (Consistency). If A = a, then M = M(a) and T = T (a) with probability
1; if A = a, and M = m, then T = T (a,m) with probability 1.
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Assumption 2 (Sequential Ignorability within Stratum). For a = 0, 1, a∗ = 0, 1, m ∈
(0, τ ], and u = 1, 2, 3,
{T (a,m),M(a∗)} ⊥ A|X, U = u (3)
and
T (a,m) ⊥M |A = a∗,X, U = u. (4)
Assumptions 1 is a standard assumption for causal inference with no unmeasured con-
founding. Assumption 2 is a standard assumption for mediation analysis in U = 1. For
U = 2, 3, Assumption 2 reduces to the standard assumption of conditional exchangeability
within stratum. Based on Assumptions 1 - 2, we are able to connect the stratum-specific
natural indirect and direct effects and stratum-specific total effects with the distribution
of the observed data given stratum membership as follows.
Theorem 1. Under Assumptions 1 - 2, for stratum with U = 1, the stratum-specific natural
indirect effect NIE1(t;x) is equal to∫ t
0
{1− Pr(T < t|M = m,X = x, A = 1, U = 1)}
× {dFM |X=x,A=1,U=1(m)− dFM |X=x,A=0,U=1(m)}
+ Pr(M ≤ t|X = x, A = 0, U = 1)− Pr(M ≤ t|X = x, A = 1, U = 1),
and the stratum-specific natural direct effect NDE1(t;x) is equal to∫ t
0
{Pr(T < t|M = m,X = x, A = 0, U = 1)
−Pr(T < t|M = m,X = x, A = 1, U = 1)} dFM |X=x,A=0,U=1(m).
Under Assumptions 1 and 2, for stratum with U = 2, the stratum-specific total effect
TE2(t;x) is equal to
Pr(T ≥ t|A = 1,X = x, U = 2)− Pr(T ≥ t|A = 0,X = x, U = 2);
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and for stratum with U = 3, the stratum-specific total effect TE3(t;x) is equal to
Pr(T ≥ t|A = 1,X = x, U = 3)− Pr(T ≥ t|A = 0,X = x, U = 3).
The proof of Theorem 1 is given in Appendix A.1. Since U is unobserved, we cannot
use Theorem 1 directly to identify those stratum-specific effects from observed data. To do
so, one would further assume
Assumption 3 (Stratum Membership Independent of Treatment). With probability one,
U is conditional independent of A given X.
Assumption 4 (Restriction on Stratum-Specific Distributions). With probability one,
Pr(M(0) = m|X = x, U = 2) =g1 {Pr(M(0) = m|X = x, U = 1);x} ,
Pr(T (0) ≥ t|M(0) = m,X = x, U = 2) =g2 {Pr(T (0) ≥ t|M(0) = m,X = x, U = 1);x} ,
Pr(T (1) ≥ t|X = x, U = 2) =g3 {Pr(T (1) ≥ t|X = x, U = 3);x} ,
for some known functions gk(·;x) (k = 1, 2, 3).
Assumption 5 (Non-Informative Censoring and Sufficient Follow-up). (M,T, U) is con-
ditionally independent of C given A and X, and the upper bound of the support of T is no
larger than that of C.
Assumption 3 requires that the stratum membership is not affected by the treatment
assignment A given covariates X. Assumption 4 requires some knowledge on the rela-
tionships of stratum-specific event time distributions. The first part of Assumption 5 is a
standard assumption for non-informative censoring time. The second part of Assumption 5
is an extension of the independent censoring and sufficient follow-up assumption in Maller
and Zhou (1992) for nonparametric estimation of cured proportion in censored data. The
assumption on the upper bounds of the supports ensures sufficient observation of the tail
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behaviour of the event times for identification of stratum membership. By further assuming
Assumptions 3 - 5, we obtain the identification results in Theorem 2, whose proof is given
in Appendix A.2.
Theorem 2. Under Assumptions 1 - 5, the stratum-specific effects can be identified, with
identification formulas given in (A.2) - (A.5).
Theorem 2 gives the identification result based on nonparametric models for U and
for (M,T ) given U with minimum assumptions. In particular, Assumption 4 requires
some modeling assumptions to be made. In practice, we may consider additional model
assumptions for U and (M,T ) to gain power in understanding the causal effects. In the
next section, we extend the multistate modeling idea in the literature of semi-competing
risks data to form such a model.
2.4. Modeling assumptions
One way to model semi-competing risks data is to use a multistate framework (Xu et al.
2010). In multistate analysis of semi-competing risks data, usually three states (states 1
- 3) are involved, corresponding to healthy (state 1), illness (state 2), and death (state 3)
in an illness-death model. All subjects starts at state 1. A subject enters state 2 if he/she
develops the intermediate event, while he/she enters state 3 if he/she develops the primary
event. In traditional illness-death model for semi-competing risks data, three processes
moving from one state to another are modeled: (1) healthy to illness (state 1 to 2), (2)
illness to death (state 2 to 3), and (3) healthy to death (state 1 to 3).
Here, we extend the idea and model the processes moving from one state to another in
different strata defined in Section 2.2.. For subjects with U = 1 and subjects with U = 2
receiving A = 0, the processes of healthy to illness and illness to death are involved and
we model the time to the nonterminal event M and the residual time R ≡ T −M . We
assume that M and R are conditionally independent given A,X, and U . This serves two
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purposes: to obtain a tractable EM algorithm in Appendix B, and to avoid the problem
of induced informative censoring caused by residual dependence between M and R (Wang
and Wells 1998; Lin et al. 1999). For subjects with U = 2 receiving A = 1 and subjects
with U = 3, the process of healthy to death is involved. This proposed model is related to
but different from the illness-death model, in that the transition structure depends on the
principal strata in our proposed model.
Suppose that for a subject with U = 1, the nonterminal event time follows a proportional
hazards model with hazard function given by
λ
(1)
M (t|A = a,X = x) = λ1(t) exp
(
βM1a+ γ
T
M1x
)
,
and the gap time between the occurrences of nonterminal and terminal events R follows a
proportional hazards model with hazard function given by
λ
(1)
R (r|A = a,X = x) = λ2(r) exp
(
βR1a+ γ
T
R1x
)
.
Suppose that for subject with U = 2 and unexposed to treatment (A = 0), the nonterminal
event time follows a proportional hazards model with hazard function given by
λ
(2)
M (t|A = 0,X = x) = λ1(t) exp
(
βM2 + γ
T
M2x
)
,
and the gap time between the occurrences of nonterminal and terminal events follows
another proportional hazards model with hazard function given by
λ
(2)
R (r|A = 0,X = x) = λ2(r) exp
(
βR2 + γ
T
R2x
)
.
Here, subjects with U = 1 and subjects with U = 2 unexposed to treatment share the same
baseline hazard functions, although the hazard ratios for covariates may be different. The
parameters βM1 and βR1 are the log hazard ratios of treatment on the nonterminal event
time and gap time, respectively, for subjects with U = 1; the parameters βM2 and βR2 are
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the log hazard ratios on the nonterminal event time and gap time, respectively, comparing
subjects with U = 1 and U = 2 who both unexposed to treatment with baseline covariates
value X = 0.
For subject with U = 2 and exposed with treatment (A = 1), we assume that the
terminal event time follows a proportional hazards model with hazard function given by
λ
(2)
T (t|A = 1,X = x) = λ3(t) exp
(
βT2 + γ
T
T2x
)
.
For subject with U = 3, we suppose that the terminal event time follows a proportional
hazards model with hazard function given by
λ
(3)
T (t|A = a,X = x) = λ3(t) exp
(
βT3a+ γ
T
T3x
)
.
Note that the terminal event times for subject with U = 3 and subject with U = 2 exposed
to treatment share the same baseline hazard function. The parameter βT3 is the log hazard
ratio of treatment on the terminal event time for subjects with U = 3, while βT2 is the log
hazard ratio of the terminal event time comparing subjects with U = 3 and A = 0 with
subjects with U = 2 and A = 1, with the same covariates value X = 0.
The natural indirect and direct effects in stratum with U = 1 can be presented as
NIE1(t|X = x) =
∫ t
0
exp
{
−Λ2(t−m)eβR1+γTR1x
}
λ1(m)e
γTM1x
×
[
eβM1 exp
{
−Λ1(m)eβM1+γTM1x
}
− exp
{
−Λ1(m)eγTM1x
}]
dm
+ exp
{
−Λ1(t)eβM1+γTM1x
}
− exp
{
−Λ1(t)eγTM1x
}
and
NDE1(t|X = x) =
∫ t
0
[
exp
{
−Λ2(t−m)eβR1+γTR1x
}
− exp
{
−Λ2(t−m)eγTR1x
}]
× λ1(m)eγTM1x exp
{
−Λ1(m)eγTM1x
}
dm,
11
where Λ1(t) =
∫ t
0
λ1(s)ds and Λ2(t) =
∫ t
0
λ2(s)ds. The total effects in strata with U = 2
and U = 3 are given by
TE2(t|X = x) = exp
{
−Λ3(t)eβT2+γTT2x
}
− 1 +
∫ t
0
λ1(m)e
βM2+γ
T
M2x
× exp
{
−Λ1(m)eβM2+γTM2x
}[
1− exp
{
−Λ2(t−m)eβR2+γTR2x
}]
dm
and
TE3(t|X = x) = exp
{
−Λ3(t)eβT3+γTT3x
}
− exp
{
−Λ3(t)eγTT3x
}
,
where Λ3(t) =
∫ t
0
λ3(s)ds.
As in Yu et al. (2015), we consider a multinomial logistic regression model on the
stratum membership. In particular, we assume
w1(x;α) = Pr(U = 1|X = x) =
exp
(
αT1 x˜
)
1 + exp (αT1 x˜) + exp (α
T
2 x˜)
,
w2(x;α) = Pr(U = 2|X = x) =
exp
(
αT2 x˜
)
1 + exp (αT1 x˜) + exp (α
T
2 x˜)
,
and w3(x;α) = Pr(U = 3|X = x) = {1 + exp
(
αT1 x˜
)
+ exp
(
αT2 x˜
)}−1, where α =
(αT1 ,α
T
2 )
T and x˜ = (1,xT)T. Then, the marginalized stratum-specific natural indirect and
direct effects are given by
NIE1(t) = Pr{T (1,M(1)) ≥ t|U = 1} − Pr{T (1,M(0)) ≥ t|U = 1}
=
∫
NIE1(t|X = x)w1(x;α)dF (x)∫
w1(x;α)dF (x)
and
NDE1(t) = Pr{T (1,M(0)) ≥ t|U = 1} − Pr{T (0,M(0)) ≥ t|U = 1}
=
∫
NDE1(t|X = x)w1(x;α)dF (x)∫
w1(x;α)dF (x)
,
where F (·) is the cumulative distribution function of X.
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2.5. Nonparametric Maximum Likelihood Estimation
For a random sample of n subjects, the observed semi-competing risks data are given by
O = {Oi : i = 1, . . . , n}, where
Oi = {∆Mi , Zi,∆Ti , Yi, Ai,X i}.
For i = 1, . . . , n, if ∆Mi = 1, then the likelihood corresponding to subject i is given by
L˜i1(Oi) = Pr (Ui = 1|X i) Pr
(
Zi, Yi,∆
T
i |Ui = 1,X i, Ai
)
+ I (Ai = 0) Pr (Ui = 2|X i) Pr
(
Zi, Yi,∆
T
i |Ui = 2,X i, Ai = 0
)
;
if ∆Mi = 0 and ∆Ti = 1, then the likelihood corresponding to subject i is given by
L˜i2(Oi) = Pr (Ui = 3|X i) Pr
(
Yi,∆
T
i |Ui = 3,X i
)
+ I (Ai = 1) Pr (Ui = 2|X i) Pr
(
Yi,∆
T
i |Ui = 2,X i, Ai = 1
)
;
and if ∆Mi = ∆Ti = 0, then the likelihood corresponding to subject i is given by
L˜i3(Oi) = Pr (Ui = 1|X i) Pr
(
Zi,∆
M
i , Yi,∆
T
i |Ui = 1,X i
)
+ Pr (Ui = 2|X i)
{
I (Ai = 0) Pr
(
Zi,∆
M
i , Yi,∆
T
i |Ui = 2,X i, Ai = 0
)
+I (Ai = 1) Pr
(
Yi,∆
T
i |Ui = 2,X i, Ai = 1
)}
+ Pr (Ui = 3|X i) Pr
(
Yi,∆
T
i |Ui = 3,X i
)
.
Therefore, the likelihood function for the observed data O is given by
n∏
i=1
L˜i1(Oi)∆Mi
{
L˜i2(Oi)∆Ti L˜i3(Oi)1−∆Ti
}1−∆Mi
.
We consider the nonparametric maximum likelihood estimation such that the estimators
for Λ1, Λ2, and Λ3 are step functions. In particular, let 0 < t11 < · · · < t1m1 < ∞ be the
ordered sequence of event times Zi’s with ∆Mi = 1; let 0 < t21 < · · · < t2m2 < ∞ be the
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ordered sequence of gap times Vi ≡ Yi − Zi’s with ∆Mi = ∆Ti = 1; and let 0 < t31 < · · · <
t3m3 < ∞ be the ordered sequence of event times Yi’s with ∆Mi = 0 and ∆Ti = 1. Let λkl
be the jump size for Λk at tkl for k = 1, 2, 3 and l = 1, . . . ,mk. Write ηM1 = (βM1,γM1)T,
ηR1 = (βR1,γR1)
T, ηM2 = (βM2,γM2)T, ηR2 = (βR2,γR2)T, ηT2 = (βT2,γT2)T, ηT3 =
(βT3,γT3)
T, θ = (ηTM1,ηTR1,ηTM2,ηTR2,ηTT2,ηTT3,αT)T, and A = (Λ1,Λ2,Λ3)T. We maximize
the objective function
Ln(θ,A) =
n∏
i=1
Li1(θ,A)∆Mi
{
Li2(θ,A)∆Ti Li3(θ,A)1−∆Ti
}1−∆Mi
,
where
Li1(θ,A) =w1(X i;α)Λ1{Zi}eηTM1W i exp
(
−eηTM1W i
∑
t1l≤Zi
λ1l
)
×
(
Λ2{Vi}eηTR1W i
)∆Ti
exp
(
−eηTR1W i
∑
t2l≤Vi
λ2l
)
+ I(Ai = 0)w2(X i;α)Λ1{Zi}eηTM2X˜i exp
(
−eηTM2X˜i
∑
t1l≤Zi
λ1l
)
×
(
Λ2{Vi}eηTR2X˜i
)∆Ti
exp
(
−eηTR2X˜i
∑
t2l≤Vi
λ2l
)
,
Li2(θ,A) =I(Ai = 1)w2(X i;α)
(
Λ3{Yi}eηTT2X˜i
)∆Ti
exp
(
−
∑
t3l≤Yi
λ3le
ηTT2X˜i
)
+ w3(X i;α)
(
Λ3{Yi}eηTT3W i
)∆Ti
exp
(
−
∑
t3l≤Yi
λ3le
ηTT3W i
)
,
Li3(θ,A) =Li2(η,A) + w1(X i;α) exp
(
−
∑
t1l≤Zi
λ1le
ηTM1W i
)
+ I(Ai = 0)w2(X i;α) exp
(
−
∑
t1l≤Zi
λ1le
ηTM2X˜i
)
,
W i = (Ai,X
T
i )
T, and Λk{t} is the jump size of Λk at time t for k = 1, 2, 3.
By treating Ui (i = 1, . . . , n) as missing data, we propose an EM algorithm to maximize
this objective function. The details of the EM algorithm are given in Appendix B. We
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write (θ̂, Â) as the estimators. The indirect and direct effects in stratum with U = 1 can
then be estimated by
N̂IE1(t;x) =
∑
t1j≤t
exp
− ∑
t2k≤t−t1j
λ̂2ke
θ̂
T
R1x˜
 λ̂1j
×
{
eθ̂
T
M1x˜ exp
(
−
j∑
k=1
λ̂1ke
θ̂
T
M1x˜
)
− eγ̂TM1x exp
(
−
j∑
k=1
λ̂1ke
γ̂TM1x
)}]
+ exp
−∑
t1j≤t
λ̂1je
θ̂
T
M1x˜
− exp
−∑
t1j≤t
λ̂1je
γ̂TM1x
 (5)
and
N̂DE1(t;x) =
∑
t1j≤t
exp
− ∑
t2k≤t−t1j
λ̂2ke
θ̂
T
R1x˜
− exp
− ∑
t2k≤t−t1j
λ̂2ke
γ̂TR1x

×λ̂1jeγ̂TM1x exp
(
−
j∑
k=1
λ̂1ke
γ̂TM1x
)]
. (6)
The total effects in strata with U = 2 and U = 3 can be estimated by
T̂E2(t;x) = exp
−∑
t3j≤t
λ̂3je
θ̂
T
T2x˜
− 1
+
∑
t1j≤t
λ̂1jeθ̂TM2x˜ exp(− j∑
k=1
λ̂1ke
θ̂
T
M2x˜
)1− exp
− ∑
t2k≤t−t1j
λ̂2ke
θ̂
T
R2x˜

 (7)
and
T̂E3(t;x) = exp
−∑
t3j≤t
λ̂3je
θ̂
T
T3x˜
− exp
−∑
t3j≤t
λ̂3je
γ̂TT3x
 . (8)
The marginalized stratum-specific indirect and direct effects in stratum with U = 1 can be
estimated by
N̂IE1(t) =
∑n
i=1w1(X i; α̂)N̂IE1(t;X i)∑n
i=1 w1(X i; α̂)
(9)
and
N̂DE1(t) =
∑n
i=1w1(X i; α̂)N̂DE1(t;X i)∑n
i=1 w1(X i; α̂)
, (10)
respectively.
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2.6. Asymptotic Properties
We study the asymptotic properties of the estimators under the semiparametric model in
Section 2.4.. Under suitable regularity conditions, the estimators (θ̂, Â) has the usual large
sample properties, including consistency and asymptotic normality, as given in Theorem 3
below. Let θ0, Λ10, Λ20, and Λ30 be the true values of θ, Λ1, Λ2, and Λ3, respectively, ‖ · ‖
be the Euclidean norm, and τk be the upper limit of the support of Λ̂k for k = 1, 2, 3.
Theorem 3. Under regularity conditions,
∥∥∥θ̂ − θ0∥∥∥+ 3∑
k=1
sup
t∈[0,τk]
∣∣∣Λ̂k(t)− Λk0(t)∣∣∣
converges to zero almost surely. In addition,
√
n{θ̂−θ0, Λ̂1(·)−Λ10)(·), Λ̂2(·)−Λ20)(·), Λ̂3(·)−
Λ30)(·)} converges weakly to a zero-mean Gaussian process in the Banach space Rm ×
l∞(A1) × l∞(A2) × l∞(A3), where m is the dimension of θ and Ak is the unit ball in the
space of functions on [0, τk] with bounded variation for k = 1, 2, 3.
Theorem 4. Under regularity conditions, the estimators for stratum-specific effects given
in (5)-(10) are consistent and asymptotically normal.
Since the form of the limiting variances of the stratum-specific effects is complicated,
we estimate the variance of the estimators by a nonparametric bootstrap procedure in all
numerical studies.
3. Simulation Studies
We conducted simulation studies to examine the performance of the proposed methods. We
generated two covariates X1 ∼ N(0, 1) and X2 ∼ Unif(0, 1) and generated the treatment
indicator A ∼ Bin(0.5) to reflect 1:1 randomization. We set Λ1(t) = t, Λ2(t) = 0.2t,
and Λ3(t) = log(1 + t), while the true values of the other parameters are shown in Table
16
1, along with the simulation results. We generated a censoring time C ∼ Unif(0, 15)
to obtain approximately 51% and 26% censoring rates for the nonterminal and terminal
events, respectively. The proportions of subjects with U = 1, 2, 3 are approximately 31%,
41%, and 28%, respectively.
We considered 1000 replicates with sample sizes n = 1000 and 2000, where 100 boot-
strap samples were used for variance estimation. Table 1 shows the simulation results,
where Bias, SE and SEE denote, respectively, the averaged bias, empirical standard error
and averaged standard error estimates, and CP stands for the empirical coverage prob-
ability of the 95% confidence intervals. All examined replications converge with a 10−6
convergence criterion. The parameter estimators are virtually unbiased. The bootstrap
variance estimator overestimates the true variability for some of the parameters, but it gets
more accurate when sample size increases.
The estimators for the baseline cumulative hazard functions only take jump till the last
observation times, such that the estimates after the last observation time is not meaningful.
Therefore, to summarize the performance of the baseline hazard estimators, for every time
point t, we only consider the replicates with last observation time greater than t. Figure 1
shows the median of the estimated baseline hazard functions, among such replicates. We
plot till the time point at which at least 800 replicates have meaningful estimates. The
bias gets smaller as sample size increases.
Table 2 shows the performance of the estimated stratum-specific indirect and direct
effects in stratum with U = 1 and X = (0.5, 0.5)T, as well as the estimated total effects
for strata with U = 2, 3 and the same covariate values. Similarly, for any t the average
was taken over all the replicates with estimators that have last jump time no less than t.
The bias gets smaller as sample size increases. The variance estimator is accurate and the
coverage probability is close to the nominal level when sample size is large.
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Table 1. Simulation Results for Regression Parameters
True n = 1000 n = 2000
Value Bias SE SEE CP Bias SE SEE CP
βM1 0.5 0.008 0.224 0.261 0.97 0.006 0.147 0.168 0.97
γM1 0.5 0.010 0.091 0.095 0.96 0.005 0.063 0.063 0.94
0.5 0.014 0.269 0.296 0.96 0.010 0.192 0.195 0.96
βR1 0.5 −0.043 0.276 0.334 0.97 −0.025 0.161 0.202 0.97
γR1 −0.2 −0.011 0.095 0.102 0.96 −0.004 0.065 0.067 0.95
−0.2 0.001 0.308 0.332 0.97 0.002 0.212 0.214 0.95
βM2 −0.2 0.005 0.503 0.599 0.98 −0.002 0.327 0.380 0.97
γM2 0.4 0.025 0.123 0.154 0.98 0.011 0.078 0.090 0.96
0.5 0.017 0.393 0.476 0.98 0.012 0.252 0.287 0.97
βR2 0.4 −0.068 0.586 0.699 0.97 −0.028 0.358 0.435 0.96
γR2 0.5 −0.013 0.187 0.230 0.96 −0.002 0.115 0.138 0.97
0.5 −0.020 0.476 0.546 0.97 −0.002 0.303 0.337 0.96
βT2 0.0 0.028 0.485 0.523 0.98 0.011 0.357 0.359 0.96
γT2 −0.5 0.015 0.175 0.197 0.98 0.012 0.124 0.132 0.97
−0.2 −0.018 0.435 0.509 0.98 0.009 0.312 0.324 0.95
βT3 0.2 −0.044 0.410 0.448 0.98 −0.034 0.334 0.332 0.96
γT3 −0.2 −0.035 0.107 0.118 0.95 −0.024 0.076 0.078 0.95
0.0 −0.017 0.371 0.402 0.96 −0.029 0.265 0.261 0.95
α1 0.0 0.009 0.199 0.213 0.96 0.010 0.148 0.146 0.95
0.3 −0.005 0.113 0.113 0.95 −0.003 0.078 0.078 0.95
0.1 −0.002 0.343 0.367 0.96 −0.007 0.256 0.253 0.95
α2 0.2 0.025 0.296 0.321 0.96 0.010 0.201 0.211 0.96
−0.5 −0.019 0.155 0.175 0.97 −0.019 0.108 0.114 0.95
0.3 −0.023 0.491 0.537 0.97 0.000 0.342 0.355 0.96
NOTE: Bias, SE and SEE denote, respectively, the mean bias,
empirical standard error and mean standard error estimator. CP
stands for the empirical coverage probability of the 95% confi-
dence interval.
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Table 2. Simulation Results for Stratum-Specific Mediation Effects and Total Effects
True n = 1000 n = 2000
t Value Bias SE SEE CP Bias SE SEE CP
NDE1 2 −0.11 0.014 0.056 0.070 0.97 0.007 0.031 0.041 0.97
4 −0.17 0.018 0.090 0.106 0.96 0.010 0.052 0.066 0.97
6 −0.18 0.020 0.096 0.107 0.94 0.010 0.057 0.069 0.96
NIE1 2 −0.04 −0.001 0.022 0.025 0.97 0.000 0.015 0.017 0.97
4 −0.03 −0.001 0.016 0.018 0.97 −0.001 0.011 0.012 0.96
6 −0.02 −0.001 0.010 0.011 0.97 0.000 0.007 0.007 0.96
TE2 2 −0.10 −0.036 0.158 0.175 0.97 −0.022 0.115 0.126 0.97
4 0.10 −0.046 0.159 0.180 0.96 −0.026 0.113 0.127 0.97
6 0.17 −0.047 0.136 0.156 0.97 −0.027 0.097 0.109 0.97
8 0.18 −0.044 0.115 0.131 0.96 −0.025 0.084 0.093 0.96
TE3 2 −0.07 0.021 0.139 0.147 0.97 0.015 0.117 0.114 0.95
4 −0.06 0.031 0.119 0.126 0.98 0.022 0.101 0.099 0.96
6 −0.06 0.033 0.101 0.107 0.97 0.024 0.086 0.085 0.96
8 −0.05 0.033 0.088 0.093 0.97 0.024 0.075 0.074 0.96
NOTE: Bias, SE and SEE denote, respectively, the mean bias, empir-
ical standard error and mean standard error estimator. CP stands for
the empirical coverage probability of the 95% confidence interval.
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Figure 1. Performance of the estimated baseline cumulative hazard functions.
4. Application
We consider application of the proposed methods to a prostate cancer clinical trial. NCIC
Clinical Trials Group PR.3/Medical Research Council PR07/Intergroup T94-0110 is a ran-
domized controlled trial of patients with locally advanced prostate cancer. The primary ob-
jective is to determine whether the addition of radiotherapy (RT) to androgen-deprivation
therapy (ADT) prolonged overall survival, defined as time from random assignment to
death from any cause. One thousand two hundred and five patients with locally advanced
prostate cancer were recruited and randomly assigned between 1995 and 2005, 602 to ADT
alone and 603 to ADT + RT. These patients were either with T3-4, N0/Nx, M0 prostate
cancer or with T1-2 disease with either prostate-specific antigen (PSA) of more than 40µg/L
or PSA of 20 to 40µg/L plus Gleason score of 8 to 10. In the final report of the study
(Mason et al. 2015), at a median follow-up time of 8 years, 465 patients had died. Overall
survival was significantly improved in the patients allocated to ADT + RT (hazard ratio
0.70 with 95% CI, 0.57 to 0.85; P<.001).
In addition to the primary outcome of death, the study also collected data on time to
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disease progression, which was defined as the first of any of the following events: biochemical
progression, local progression, or development of metastatic disease. We analyzed the data
to reveal the proportions of the treatment effect on overall survival that are mediated by
disease progression. Particularly, we adjusted for initial PSA level (< 20 vs. 20 to 50, vs.
>50g/L) and Gleason score(8 vs. 8 to 10).
We analyzed the data using the proposed approach, with 100 bootstrap samples for
variance estimation. The parameter estimates for regression coefficients for the event time
processes are shown in Table 3. For stratum with U = 1, ADT + RT is associated with
a decreased risk of disease progression, while it is associated with an increased risk from
disease progression to death. For stratum with U = 3, ADT + RT is associated with a
decreased risk of death. The effects are not significant at 0.05 level. For stratum with
U = 1, a subject with initial PSA level >50 g/L is associated with significantly increased
risk of disease progression, compared to a similar subject with initial PSA level <20 g/L;
and a subject with Gleason score 8-10 is associated with significantly decreased risk of
disease progression, compared to a similar subject with Gleason score <8.
Table 4 shows the parameter estimators of the logistic regression model for stratum
membership. By averaging over the stratum membership probabilities over all subjects
given their covariate values, the average probabilities of belong to strata U = 1, 2, and 3 are
40.1%, 25.7%, and 34.2%, respectively. To verify if the model is reasonable, we estimated
the stratum-specific survival functions for every subject and summarize the subject-specific
survival function by weighting them by his/her stratum membership probabilities. We
average the estimated survival functions for subjects assigned to ADT+RT versus ADT,
and plot them against the survival function estimators from the Kaplan Meier methods
and the proportional hazards model. The results are shown in Figure 2. The estimated
population-average survival functions for ADT+RT and ADT groups are similar to those
from the Kaplan Meier methods and the proportional hazards model, especially for time
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Table 3. Parameter Estimates for Regression Coefficients for Event Time Processes
Process
U = 1
Health → Disease Disease → Death
Est SEE p-value Est SEE p-value
ADT + RT −0.825 0.987 0.403 0.460 0.658 0.484
Initial PSA Level (20 to 50 g/L) 0.321 0.530 0.545 −0.097 0.305 0.751
Initial PSA Level (> 50 g/L) 1.607 0.566 0.005 0.065 0.342 0.848
Gleason Score (8-10) −2.008 0.413 0.0000 −0.378 0.241 0.117
Process
U = 2, ADT
Health → Disease Disease → Death
Est SEE p-value Est SEE p-value
Intercept −1.917 1.587 0.227 −0.557 3.548 0.875
Initial PSA Level (20 to 50 g/L) 0.663 1.005 0.510 −0.304 0.863 0.725
Initial PSA Level (> 50 g/L) 1.619 0.904 0.073 −0.104 0.940 0.912
Gleason Score (8-10) 0.674 0.952 0.479 −0.106 3.381 0.975
Process
U = 2, ADT + DT U = 3
Health → Death Health → Death
Est SEE p-value Est SEE p-value
Intercept −3.212 7.339 0.662 −0.446 0.875 0.610
Initial PSA Level (20 to 50 g/L) 1.146 5.416 0.832 −0.022 0.649 0.972
Initial PSA Level (> 50 g/L) 1.601 5.545 0.773 −0.883 0.641 0.168
Gleason Score (8-10) 1.624 4.630 0.726 −0.514 0.486 0.290
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Table 4. Parameter Estimates for Regression Coefficients for Stratum Membership
α1 α2
Est SEE p-value Est SEE p-value
Intercept 0.205 0.441 0.643 0.291 0.743 0.695
Initial PSA Level (20 to 50 g/L) 0.090 0.583 0.877 0.625 1.054 0.553
Initial PSA Level (> 50 g/L) −0.684 0.517 0.186 0.004 0.929 0.996
Gleason Score (8-10) 0.134 0.415 0.746 −1.495 0.732 0.041
before 10 years when data are not sparse, indicating proper fit of the proposed approach.
Figure 3 shows the estimated marginalized stratum-specific indirect and direct effects
(with 95% confidence intervals) for stratum with U = 1. The estimated natural indirect
effect is positive and increasing over time, and the estimated natural direct effect is slightly
negative over time. However, the 95% confidence intervals are wide such that the stratum-
specific natural indirect and direct effects are not significant different from zero. The total
effect in stratum with U = 1 is positive and increasing over time, corresponding to an
increased survival probability assigned to ADT+RT versus ADT in stratum with U = 1.
It is worth noting that the primary analysis for the data shows that overall survival was
significantly improved in the patients allocated to ADT + RT compared to ADT. However,
our analysis failed to obtain a significant stratum-specific overall effect of ADT + RT. The
main reason is that by identifying subjects to different strata, the sample size to estimate
parameters in each stratum is much smaller than that for the proportional hazards model
based on all available subjects. In addition, the proposed model has much more parameters,
such that the variability for parameter estimation significantly increases.
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Figure 2. Estimated survival functions from the proposed, Kaplan-Meier, and proportional
hazards model approaches.
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Figure 3. Estimated stratum-specific indirect and direct effects in stratum with U = 1.
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5. Discussion
Semi-competing risks data are frequently observed in medical studies, where the termi-
nal event time may censor the intermediate event time but not vice versa. To define
and estimate causal contrasts of the effect of a treatment to the terminal and intermediate
events, we introduced a novel principal stratification framework that distinguishes suscepti-
ble and non-susceptible subjects given different treatments, and defined the natural indirect
and direct effects in the stratum where the times to intermediate and terminal events are
well-defined given both treatments. We provided reasonable assumptions to identify the
stratum-specific natural indirect and direct effects, proposed a semiparametric model, and
studied an EM algorithm to obtain the nonparametric maximum likelihood estimators of
model parameters. We showed that the estimators are consistent and asymptotically effi-
cient estimated under mild regularity conditions, and their performance are satisfactory in
finite sample numerical studies.
In identifying the stratum-specific natural indirect and direct effects, we assumed that
there are no subjects who are susceptible to the intermediate event under treatment (A = 1)
and non-susceptible under control (A = 0). This assumption may need careful examination
based on scientific understanding of how treatment may affect the intermediate event. In
our data application, we assessed this assumption by fitting the proposed model with
switched treatment indicator labels of ADT+RT and ADT. The estimated probability of
belonging to stratum with U = 2 (equivalent to the fourth stratum in the original labeling)
is very low, suggesting that the assumption on non-existence of the fourth stratum may
be valid. In some applications, this fourth stratum may indeed exist. In the literature of
principal stratification for uncensored data with four or more strata, the effect of interest
often can only be interval identified. Interval identification with a regression model often
results in a complicated solution manifold, with properties often not well understood. We
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plan to explore this problem in a future study.
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APPENDIX A Identification of Stratum-Specific Effects
A.1 Proof of Theorem 1
Note that (3) in Assumption 2 implies
T (a,m) ⊥ A|M(a∗) = m∗,X, U = 1. (A.1)
In stratum U = 1, for a given t ≤ τ and any a, a∗, we have
Pr{T (a,M(a∗)) ≥ t|X = x, U = 1}
=
∫
Pr{T (a,m) ≥ t|M(a∗) = m,X = x, U = 1}dFM(a∗)|X=x,U=1(m)
=
∫
Pr{T (a,m) ≥ t|M(a∗) = m,A = a∗,X = x, U = 1}dFM(a∗)|X=x,U=1(m)
=
∫
Pr{T (a,m) ≥ t|A = a∗,X = x, U = 1}dFM(a∗)|X=x,U=1(m)
=
∫
Pr{T (a,m) ≥ t|A = a,X = x, U = 1}dFM(a∗)|X=x,U=1(m)
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=∫
Pr{T (a,m) ≥ t|M(a) = m,A = a,X = x, U = 1}dFM(a∗)|X=x,U=1(m)
=
∫ t
0
Pr{T (a,m) ≥ t|M(a) = m,A = a,X = x, U = 1}dFM(a∗)|X=x,U=1(m)
+
∫ ∞
t
Pr{T (a,m) ≥ t|M(a) = m,A = a,X = x, U = 1}dFM(a∗)|X=x,U=1(m)
=
∫ t
0
Pr{T (a,m) ≥ t|M(a) = m,A = a,X = x, U = 1}dFM(a∗)|X=x,U=1(m)
+ Pr(M(a∗) ≥ t|X = x, U = 1),
where the second equality follows from (A.1), the third and fifth equalities follow from
(4) in Assumption 2, and the last equality follows from the fact that T (a,m) ≥ t with
probability one for any m ≥ t given U = 1. Then, following (3) in Assumption 2 and
Assumption 1, the proceeding expression is equal to∫ t
0
Pr{T (a) ≥ t,M(a) = m|A = a,X = x, U = 1}
Pr{M(a) = m|A = a,X = x, U = 1} dFM(a∗)|A=a∗,X=x,U=1(m)
+ Pr(M(a∗) ≥ t|A = a∗,X = x, U = 1)
=
∫ t
0
Pr(T ≥ t|M = m,A = a,X = x, U = 1)dFM |A=a∗,X=x,U=1(m)
+ Pr(M > t|A = a∗,X = x, U = 1).
Then, the natural indirect and direct effects, as defined in equations (1) and (2), are equal
to
NIE1(t;x) =
∫ t
0
Pr(T ≥ t|M = m,A = 1,X = x, U = 1)
× {dFM |A=1,X=x,U=1(m)− dFM |A=0,X=x,U=1(m)}
+ Pr(M > t|A = 1,X = x, U = 1)− Pr(M > t|A = 0,X = x, U = 1)
and
NDE1(t;x) =
∫ t
0
{Pr(T ≥ t|M = m,A = 1,X = x, U = 1)
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−Pr(T ≥ t|M = m,A = 0,X = x, U = 1)} dFM |A=0,X=x,U=1(m).
For stratum with U = 2, we have
TE2(t;x) = Pr(T (1) ≥ t|A = 1,X = x, U = 2)− Pr(T (0) ≥ t|A = 0,X = x, U = 2)
= Pr(T ≥ t|A = 1,X = x, U = 2)− Pr(T ≥ t|A = 0,X = x, U = 2),
where the two equalities follow from Assumptions 2 and 1, respectively. Similarly, for
stratum with U = 3, we have
TE3(t;x) = Pr(T (1) ≥ t|A = 1,X = x, U = 3)− Pr(T (0) ≥ t|A = 0,X = x, U = 3)
= Pr(T ≥ t|A = 1,X = x, U = 3)− Pr(T ≥ t|A = 0,X = x, U = 3),
A.2 Proof of Theorem 2
We first consider the identification of stratum membership probabilities, as the first step
to identify the stratum-specific effects. By the definition of the strata, we have
Pr(M <∞|A = 0,X = x) = Pr(M(0) <∞|A = 0,X = x)
= Pr(M(0) <∞,M(1) <∞|A = 0,X = x)
+ Pr(M(0) <∞,M(1) =∞|A = 0,X = x)
= Pr(U = 1|A = 0,X = x) + Pr(U = 2|A = 0,X = x)
= Pr(U = 1|X = x) + Pr(U = 2|X = x),
where the last equality follows from Assumption 3. Similarly, we have the following
equalites:
Pr(M <∞|A = 1,X = x) = Pr(U = 1|X = x)
Pr(M =∞|A = 0,X = x) = Pr(U = 3|X = x)
Pr(M =∞|A = 1,X = x) = Pr(U = 2|X = x) + Pr(U = 3|X = x).
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Therefore, the stratum membership probabilities Pr(U = u|X) can be identified by the
observed data if there is no censoring and we can observed if M = ∞. The identification
of the quantities in the presence of censoring is discussed in the end of the section.
We further consider the distributions of the (observed) intermediate and primary event
times to identify terms in the definition of stratum-specific effects. First, consider the case
if we observe M = m < ∞ for a subject assigned to treatment A = 1. Since it implies
M(1) <∞, this subject should have U = 1 with probability one. That is, for any m <∞,
Pr(M = m|A = 1,X = x) = Pr(M = m,M(1) ≤ T (1)|A = 1,X = x)
= Pr(M = m,M(0) ≤ T (0),M(1) ≤ T (1)|A = 1,X = x)
= Pr(M = m,U = 1|A = 1,X = x)
= Pr(M = m|U = 1, A = 1,X = x) Pr(U = 1|A = 1,X = x)
= Pr(M(1) = m|X = x, U = 1) Pr(U = 1|X = x),
where the first equality follows from Assumption 1, the second and third equalities follow
from the definition of strata, and last equality follows from Assumption 3. Similarly, we
have for any m ≤ t <∞,
Pr(T ≥ t|M = m,A = 1,X = x) =Pr(T < t,M = m|A = 1,X = x)
Pr(M = m|A = 1,X = x)
=
Pr(T ≥ t,M = m,M(1) ≤ T (1)|A = 1,X = x)
Pr(M = m,M(1) ≤ T (1)|A = 1,X = x)
=
Pr(T ≥ t,M = m,U = 1|A = 1,X = x)
Pr(M = m,U = 1|A = 1,X = x)
= Pr(T (1) ≥ t|M(1) = m,X = x, U = 1).
For the case that we observe M = m < ∞ for a subject assigned to treatment A = 0,
the subject would possibly have U = 1 or U = 2, since both strata has M(0) <∞. Then,
we have
Pr(M = m|A = 0,X = x)
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= Pr(M = m,M(0) ≤ T (0)|A = 0,X = x)
= Pr(M = m,M(0) ≤ T (0),M(1) ≤ T (1)|A = 0,X = x)
+ Pr(M = m,M(0) ≤ T (0),M(1) =∞|A = 0,X = x)
= Pr(M = m,U = 1|A = 0,X = x) + Pr(M = m,U = 2|A = 0,X = x)
= Pr(M = m|A = 0,X = x, U = 1) Pr(U = 1|X = x)
+ Pr(M = m|A = 0,X = x, U = 2) Pr(U = 2|X = x)
= Pr(M(0) = m|X = x, U = 1) Pr(U = 1|X = x)
+ g1(Pr(M(0) = m|X = x, U = 1);x) Pr(U = 2|X = x),
where the last equality follows from Assumption 4, and
Pr(T ≥ t|M = m,A = 0,X = x)
=
Pr(T ≥ t,M = m|A = 0,X = x)
Pr(M = m|A = 0,X = x)
=
Pr(T ≥ t,M = m,M(0) ≤ T (0)|A = 0,X = x)
Pr(M = m|A = 0,X = x)
=
∑
u=1,2 Pr(T (0) ≥ t|M(0) = m,X = x, U = u) Pr(M(0) = m|X = x, U = u) Pr(U = u|X = x)∑
u=1,2 Pr(M = m(0)|X = x, U = u)) Pr(U = u|X = x)
.
Then, the natural indirect effect can be presented as
NIE1(t;x) =
∫ t
0
Pr(T ≥ t|M = m,A = 1,X = x)
× {Pr(M = m|M <∞, A = 1,X = x)− h∗1(m;x)} dm
+ Pr(M ≤ t|M <∞, A = 1,X = x)−
∫ t
0
h∗1(m;x)dm. (A.2)
where h∗1(m;x) is the solution to the equation
Pr(M = m|A = 0,X = x) = h1(m;x) Pr(M <∞|A = 1,X = x)
+ g1{h1(m;x);x} {Pr(M <∞|A = 0,X = x)− Pr(M <∞|A = 1,X = x)} .
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Similarly, the natural direct effect can be presented as
NDE1(t;x) =
∫ t
0
{Pr(T ≥ t|M = m,A = 1,X = x)− h∗2(m, t;x)}h∗1(m;x)dm, (A.3)
where h∗2(m, t;x) is the solution to
Pr(T ≥ t,M = m|A = 0,X = x) = h2(m, t;x)h∗1(m;x) Pr(M <∞|A = 1,X = x)
+ g2{h2(m, t;x);x}g1{h∗1(m;x);x}
× {Pr(M <∞|A = 0,X = x)− Pr(M <∞|A = 1,X = x)} .
By similar derivations, we have
Pr(T ≥ t,M =∞|A = 1,X = x)
= Pr(T ≥ t|A = 1,X = x, U = 2) Pr(U = 2|X = x)
+ Pr(T ≥ t|A = 1,X = x, U = 3) Pr(U = 3|X = x)
=g3 {Pr(T (1) ≥ t|X = x, U = 2)}Pr(U = 2|X = x)
+ Pr(T (1) ≥ t|X = x, U = 3) Pr(U = 3|X = x),
and
Pr(T ≥ t,M =∞|A = 0,X = x) = Pr(T (0) ≥ t|X = x, U = 3) Pr(U = 3|X = x).
Then, the stratum-specific total effects for strata with U = 2 and U = 3 are
TE2(t;x) =
∫ t
0
g2{h∗2(m, t;x);x}g1 {h∗1(m;x);x} dm− g3 {h∗3(t;x);x} , (A.4)
and
TE3(t;x) = h
∗
3(t;x)− Pr(T ≥ t|M =∞, A = 0,X = x), (A.5)
where h∗3(t;x) is the solution to the equation
Pr(T = t,M <∞|A = 1,X = x) = h3(t;x) Pr(M =∞|A = 0,X = x)
32
+ g3 {h3(t;x);x} {Pr(M =∞|A = 1,X = x)− Pr(M =∞|A = 0,X = x)} .
In the special case that gk(·;x) are identity functions, i.e., the stratum-specific joint
distributions of {M(0), T0)} are the same for strata U = 1 and U = 2 given X = x, and
the stratum-specific distributions of T (0) are the same for strata U = 2 and U = 3 given
X = x, the functions h∗k’s have closed form
h∗1(m;x) = Pr(M = m|M <∞, A = 0,X = x),
h∗2(m, t;x) = Pr(T ≥ t|M = m,A = 0,X = x),
h∗3(t;x) = Pr(T < t|M =∞, A = 1,X = x).
Then, the stratum-specific effects can be identified by
NIE1(t;x) =
∫ t
0
Pr(T ≥ t|M = m,A = 1,X = x) {Pr(M = m|M <∞, A = 1,X = x)
−Pr(M = m|M <∞, A = 0,X = x)} dm
+ Pr(M ≤ t|M <∞, A = 1,X = x)− Pr(M ≤ t|M <∞, A = 0,X = x),
NDE1(t;x) =
∫ t
0
{Pr(T ≥ t|M = m,A = 1,X = x)− Pr(T ≥ t|M = m,A = 0,X = x)}
× Pr(M = m|M <∞, A = 0,X = x)dm,
TE2(t;x) =
∫ t
0
Pr(T ≥ t,M = m|M <∞, A = 1,X = x)dm
− Pr(T ≥ t|M =∞, A = 0,X = x),
and
TE3(t;x) = Pr(T ≥ t|M =∞, A = 1,X = x)− Pr(T ≥ t|M =∞, A = 0,X = x).
In the presence of censoring, we cannot observe if M =∞, such that previous formula
cannot be directly applied. However, we are still able to identify the quantities if we assume
non-informative censoring and sufficient follow-up in strata (Assumption 5). Particularly,
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we consider the marker process I(M ≤ t) along with the event time T . Then, based on
an extension of results in Maller and Zhou (1992), the probability Pr(M = ∞|A,X) can
be consistently estimated by the empirical value of the marker process at the last observed
failure time. By replacing terms related to Pr(M = ∞|A,X) by their estimators, we
identify the stratum-specific mediation effects and total effects.
APPENDIX B Details on EM Algorithm
Based on the likelihood function with known Ui, we are then able to propose an EM
algorithm treating Ui (i = 1, . . . , n) as missing data. In particular, the complete-data
log-likelihood (with known Ui for i = 1, . . . , n) is given by
ln(β,γ,α,Λ)
=
n∑
i=1
[
I(Ui = 1)
{
αT1 X˜ i + ∆
M
i
(
log Λ1{Zi}+ ηTM1W i − eη
T
R1W i
∑
t2l≤Vi
λ2l
)
+∆Mi ∆
T
i
(
log Λ2{Vi}+ ηTR1W i
)− (1−∆Ti + ∆Mi ∆Ti ) eηTM1W i ∑
t1l≤Zi
λ1l
}
+ I(Ai = 0, Ui = 2)
{
αT2 X˜ i + ∆
M
i
(
log Λ1{Zi}+ ηTM2X˜ i − eη
T
R2X˜i
∑
t2l≤Vi
λ2l
)
+∆Mi ∆
T
i
(
log Λ2{Vi}+ ηTR2X˜ i
)
− (1−∆Ti + ∆Mi ∆Ti ) eηTM2X˜i ∑
t1l≤Zi
λ1l
}
+ I(Ai = 1, Ui = 2)(1−∆Mi )
{
αT2 X˜ i + ∆
T
i
(
log Λ3{Yi}+ ηTT2X˜ i
)
− eηTT2X˜i
∑
t3l≤Yi
λ3l
}
+ I(Ui = 3)(1−∆Mi )
{
∆Ti
(
log Λ3{Yi}+ ηTT3W i
)− eηTT3W i ∑
t3l≤Yi
λ3l
}
− log
{
1 + exp
(
αT1 X˜ i
)
+ exp
(
αT2 X˜ i
)}]
.
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In the E-step of the EM algorithm, we evaluate the conditional expectation Ui for subjects
i = 1, . . . , n. In particular,
P̂r(Ui = 1) =∆
M
i
{
I(Ai = 1) + I(Ai = 0)
Bi1
Bi1 +Bi2
}
+ (1−∆Mi )(1−∆Ti )
Di1
Di1 +Di2 +Di3
P̂r(Ui = 2) =∆
M
i I(Ai = 0)
Bi2
Bi1 +Bi2
+ (1−∆Mi )∆Ti I(Ai = 1)
Ci2
Ci2 + Ci3
+ (1−∆Mi )(1−∆Ti )
Di2
Di1 +Di2 +Di3
P̂r(Ui = 3) =(1−∆Mi )∆Ti
{
I(Ai = 0) + I(Ai = 1)
Ci3
Ci2 + Ci3
}
+ (1−∆Mi )(1−∆Ti )
Di3
Di1 +Di2 +Di3
where
Bi1 = exp
{
αT1 X˜ i + η
T
M1W i + ∆
T
i
(
ηTR1W i
)− eηTM1W i ∑
t1l≤Zi
λ1l − eηTR1W i
∑
t2l≤Vi
λ2l
}
,
Bi2 = exp
{
αT2 X˜ i + η
T
M2X˜ i + ∆
T
i
(
ηTR2X˜ i
)
− eηTM2X˜i
∑
t1l≤Zi
λ1l − eηTR2X˜i
∑
t2l≤Vi
λ2l
}
,
Ci2 = exp
(
αT2 X˜ i + η
T
T2X˜ i − eη
T
T2X˜i
∑
t3l≤Yi
λ3l
)
,
Ci3 = exp
(
ηTT3W i − eη
T
T3W i
∑
t3l≤Yi
λ3l
)
,
Di1 = exp
(
αT1 X˜ i − eη
T
M1W i
∑
t1l≤Zi
λ1l
)
,
Di2 = exp
(
αT2 X˜ i
){
I(Ai = 0) exp
(
−eηTM2X˜i
∑
t1l≤Zi
λ1l
)
+I(Ai = 1) exp
(
−eηTT2X˜i
∑
t3l≤Yi
λ3l
)}
,
and
Di3 = exp
(
−eηTT3W i
∑
t3l≤Yi
λ3l
)
.
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In the M-step of the EM algorithm, we maximize the conditional expectation of the
complete-data log-likelihood function. In particular, we update Λ1, Λ2, and Λ3 by
λ1l =
∑n
i=1 ∆
M
i I(Zi = t1l)∑n
i=1 (1−∆Ti + ∆Mi ∆Ti ) I(Zi ≥ t1l)Si1
,
λ2l =
∑n
i=1 ∆
M
i ∆
T
i I(Vi = t2l)∑n
i=1 ∆
M
i I(Vi ≥ t2l)Si2
,
λ3l =
∑n
i=1(1−∆Mi )∆Ti I(Yi = t3l)∑n
i=1(1−∆Mi )I(Yi ≥ t3l)Si3
,
where
Si1 =P̂r(Ui = 1)e
ηTM1W i + P̂r(Ui = 2)I(Ai = 0)e
ηTM2X˜i ,
Si2 =P̂r(Ui = 1)e
ηTR1W i + P̂r(Ui = 2)I(Ai = 0)e
ηTR2X˜i ,
Si3 =P̂r(Ui = 2)I(Ai = 1)e
ηTT2X˜i + P̂r(Ui = 3)e
ηTT3W i .
We update ηM1 by solving
n∑
i=1
∆Mi
{
P̂r(Ui = 1)W i −
∑n
j=1 I(Zj ≥ Zi)(1−∆Tj + ∆Mj ∆Tj )P̂r(Uj = 1)eη
T
M1W jW j∑n
j=1 I(Zj ≥ Zi)(1−∆Tj + ∆Mj ∆Tj )Sj1
}
= 0,
and update ηM2 by solving
n∑
i=1
∆Mi
{
P̂r(Ui = 2)I(Ai = 0)X˜ i
−
∑n
j=1 I(Zj ≥ Zi)(1−∆Tj + ∆Mj ∆Tj )P̂r(Uj = 2)I(Aj = 0)eβM2+γ
T
M2XjX˜j∑n
j=1 I(Zj ≥ Zi)(1−∆Tj + ∆Mj ∆Tj )Sj1
}
= 0.
We update ηR1 by solving
n∑
i=1
∆Mi ∆
T
i
{
P̂r(Ui = 1)W i −
∑n
j=1 I(Rj ≥ Vi)∆Mj P̂r(Uj = 1)eη
T
R1W jW j∑n
j=1 I(Rj ≥ Vi)∆Mj Sj2
}
= 0,
and update ηR2 by solving
n∑
i=1
∆Mi ∆
T
i
{
P̂r(Ui = 2)I(Ai = 0)X˜ i
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−
∑n
j=1 I(Rj ≥ Vi)∆Mj P̂r(Uj = 2)I(Aj = 0)eη
T
R2X˜jX˜j∑n
j=1 I(Rj ≥ Vi)∆Mj Sj2
}
= 0.
We update ηT2 by solving
n∑
i=1
(1−∆Mi )∆Ti
{
P̂r(Ui = 2)I(Ai = 1)X˜ i
−
∑n
j=1 I(Yj ≥ Yi)(1−∆Mj )P̂r(Uj = 2)I(Aj = 1)eη
T
T2X˜jX˜j∑n
j=1 I(Yj ≥ Yi)(1−∆Mj )Sj3
}
= 0,
and update ηT3 by solving
n∑
i=1
(1−∆Mi )∆Ti
{
P̂r(Ui = 3)W i
−
∑n
j=1 I(Yj ≥ Yi)(1−∆Mj )P̂r(Uj = 1)eη
T
T3W jW j∑n
j=1 I(Yj ≥ Yi)(1−∆Mj )Sj3
}
= 0.
Finally, we update α by solving
n∑
i=1
P̂r(Ui = 1)− exp
(
αT1 X˜ i
)
1 + exp
(
αT1 X˜ i
)
+ exp
(
αT2 X˜ i
)
 X˜ i = 0,
n∑
i=1
P̂r(Ui = 2)− exp
(
αT2 X˜ i
)
1 + exp
(
αT1 X˜ i
)
+ exp
(
αT2 X˜ i
)
 X˜ i = 0.
Starting with θ = 0 and λkl = 1/mk for k = 1, 2, 3, we iterate between the E-step and
the M-step until convergence to obtain the nonparametric maximum likelihood estimators
(θ̂, Â).
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